Data is as of January 2026. The statistic excludes the more generalized indications, which include the term ‘unspecified’, to focus solely on counting drugs where precise target diseases have been identified.
Citation formats
Worldwide top diseases 2026, by number of drugs in R&D
In 2026, there were active drugs for lung cancer, which made it the *** disease in the R&D pipeline. Breast cancer had active drugs in the R&D pipeline.Â
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how ÌÇÐÄÆƽâ°æ can support your business.
Citeline. (March 30, 2026). Leading 15 diseases worldwide by number of R&D products as of 2026 [Graph]. In ÌÇÐÄÆƽâ°æ. Retrieved August 01, 2026, from /statistics/791347/top-diseases-worldwide-by-number-of-active-drugs/
Citeline. "Leading 15 diseases worldwide by number of R&D products as of 2026." Chart. March 30, 2026. ÌÇÐÄÆƽâ°æ. Accessed August 01, 2026. /statistics/791347/top-diseases-worldwide-by-number-of-active-drugs/
Citeline. (2026). Leading 15 diseases worldwide by number of R&D products as of 2026. ÌÇÐÄÆƽâ°æ. ÌÇÐÄÆƽâ°æ Inc.. Accessed: August 01, 2026. /statistics/791347/top-diseases-worldwide-by-number-of-active-drugs/
Citeline. "Leading 15 Diseases Worldwide by Number of R&d Products as of 2026." ÌÇÐÄÆƽâ°æ, ÌÇÐÄÆƽâ°æ Inc., 30 Mar 2026, /statistics/791347/top-diseases-worldwide-by-number-of-active-drugs/
Citeline, Leading 15 diseases worldwide by number of R&D products as of 2026 ÌÇÐÄÆƽâ°æ, /statistics/791347/top-diseases-worldwide-by-number-of-active-drugs/ (last visited August 01, 2026)
Leading 15 diseases worldwide by number of R&D products as of 2026 [Graph], Citeline, March 30, 2026. [Online]. Available: /statistics/791347/top-diseases-worldwide-by-number-of-active-drugs/
